Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mohsen S, Elalfy"'
Autor:
Mohsen S. Elalfy, Mona Hamdy, Amal El-Beshlawy, Fatma S. E. Ebeid, Mohamed Badr, Julie Kanter, Baba Inusa, Amira A. M. Adly, Suzan Williams, Yurdanur Kilinc, David Lee, Caroline Fradette, Anna Rozova, Noemi Toiber Temin, Fernando Tricta, Janet L. Kwiatkowski
Publikováno v:
Blood Advances. 7:611-619
Long-term safety and efficacy data on the iron chelator deferiprone in sickle cell disease (SCD) and other anemias are limited. FIRST-EXT was a 2-year extension study of FIRST (Ferriprox in Patients With Iron Overload in Sickle Cell Disease Trial), a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a60aa18dda6796e37fbf34fa96877b8
https://doi.org/10.1182/bloodadvances.2021006778
https://doi.org/10.1182/bloodadvances.2021006778
Autor:
Mohsen S. Elalfy, MD, PhD, Gamal Esmat, Randa M. Matter, Hesham E. Abdel Aziz, Walid A. Massoud
Publikováno v:
Annals of Hepatology, Vol 12, Iss 1, Pp 54-61 (2013)
Background. The main causes of liver fibrosis in transfusion-dependent thalassemia major are hepatitis C virus (HCV) infection and hepatic iron overload. The study aimed to assess liver fibrosis in Egyptian adolescents and young adult poly-transfused
Externí odkaz:
https://doaj.org/article/3a5d4edc414d4b819033c457df13ac5e
Publikováno v:
Egyptian Journal of Pediatrics. 36:31-43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c14612ced7b6afc4eb09b3b811aeaad
https://doi.org/10.12816/0052971
https://doi.org/10.12816/0052971
Autor:
Dudley J. Pennell, John B. Porter, Maria Domenica Cappellini, Lee Lee Chan, Amal El-Beshlawy, Yesim Aydinok, Hishamshah Ibrahim, Chi-Kong Li, Vip Viprakasit, Mohsen S. Elalfy, Antonis Kattamis, Gillian Smith, Dany Habr, Gabor Domokos, Bernard Roubert, Ali Taher
Publikováno v:
Haematologica, Vol 97, Iss 6 (2012)
Background Prospective data on cardiac iron removal are limited beyond one year and longer-term studies are, therefore, important.Design and Methods Seventy-one patients in the EPIC cardiac substudy elected to continue into the 3rd year, allowing car
Externí odkaz:
https://doaj.org/article/8200d58999654e75addf9a56cafbe10d
Publikováno v:
Egyptian Journal of Pediatrics. 33:41-60
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00bafbccd45eb29c03720724e1f29914
https://doi.org/10.12816/0049375
https://doi.org/10.12816/0049375
Publikováno v:
Transfusion. 52(1)
Thalassemia is considered the most common hemoglobinopathy in Egypt and is one of its major health problems. Lifelong red blood cell (RBC) transfusion remains the main treatment for severe forms; however, RBC alloimmunization results as a complicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4b3c670a51d42307410ee2ee3ac33e1b
https://pubmed.ncbi.nlm.nih.gov/21745214
https://pubmed.ncbi.nlm.nih.gov/21745214
Autor:
Ali, Taher, Mohsen S, Elalfy, Kusai, Al Zir, Shahina, Daar, Abdullah, Al Jefri, Dany, Habr, Ulrike, Kriemler-Krahn, Bernard, Roubert, Amal, El-Beshlawy
Publikováno v:
European Journal of Haematology
This analysis evaluated the effects of deferasirox on liver iron concentration in moderate and heavily iron-overloaded patients with β-thalassaemia from the ESCALATOR trial (n = 231). Mean liver iron concentrations (LIC) decreased significantly from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8f0a3b610e47baeec9aafb52acc795e
https://pubmed.ncbi.nlm.nih.gov/21668501
https://pubmed.ncbi.nlm.nih.gov/21668501